{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:39:33Z","timestamp":1780400373239,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.7759\/cureus.16855","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T18:19:16Z","timestamp":1628014756000},"source":"Crossref","is-referenced-by-count":28,"title":["The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Rose Anne M","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Masroor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arseni","family":"Khorochkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan B","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maduka C","family":"Nnadozie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Abdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820974917","article-title":"The efficacy of Vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"13","author":"Abdel-Maboud M","year":"2020","unstructured":"Abdel-Maboud M, Menshawy A, Menshawy E, Emara A, Alshandidy M, Eid M. The efficacy of Vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. Therap Adv Gastroenterol. 2020, 13:1756284820974917. 10.1177\/1756284820974917","journal-title":"Therap Adv Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i19.3407","article-title":"Relationship between adipose tissue dysfunction, Vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease","volume":"23","author":"Cimini FA","year":"2017","unstructured":"Cimini FA, Barchetta I, Carotti S, et al.. Relationship between adipose tissue dysfunction, Vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. World J Gastroenterol. 2017, 23:3407-17. 10.3748\/wjg.v23.i19.3407","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/nu10040440","article-title":"Folate and B12 levels correlate with histological severity in NASH patients","volume":"10","author":"Mahamid M","year":"2018","unstructured":"Mahamid M, Mahroum N, Bragazzi NL, et al.. Folate and B12 levels correlate with histological severity in NASH patients. Nutrients. 2018, 10:440. 10.3390\/nu10040440","journal-title":"Nutrients"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9838","article-title":"Association between serum and dietary antioxidant micronutrients and advanced liver fibrosis in non-alcoholic fatty liver disease: an observational study","volume":"8","author":"Coelho JM","year":"2020","unstructured":"Coelho JM, Cansan\u00e7\u00e3o K, Perez RM, Leite NC, Padilha P, Ramalho A, Peres W. Association between serum and dietary antioxidant micronutrients and advanced liver fibrosis in non-alcoholic fatty liver disease: an observational study. PeerJ. 2020, 8:e9838. 10.7717\/peerj.9838","journal-title":"PeerJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4137\/IMI.S31451","article-title":"The role of vitamins in the pathogenesis of non-alcoholic fatty liver disease","volume":"11","author":"Li J","year":"2016","unstructured":"Li J, Cordero P, Nguyen V, Oben JA. The role of vitamins in the pathogenesis of non-alcoholic fatty liver disease. Integr Med Insights. 2016, 11:19-25. 10.4137\/IMI.S31451","journal-title":"Integr Med Insights"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101937","article-title":"Impact of Vitamin E on redox biomarkers in non-alcoholic fatty liver disease","volume":"42","author":"Podszun MC","year":"2021","unstructured":"Podszun MC, Frank J. Impact of Vitamin E on redox biomarkers in non-alcoholic fatty liver disease. Redox Biol. 2021, 42:101937. 10.1016\/j.redox.2021.101937","journal-title":"Redox Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S286334","article-title":"The impact of Vitamin D in non-alcoholic fatty liver disease: a cross-sectional study in patients with morbid obesity","volume":"14","author":"Borges-Canha M","year":"2021","unstructured":"Borges-Canha M, Neves JS, Mendon\u00e7a F, et al.. The impact of Vitamin D in non-alcoholic fatty liver disease: a cross-sectional study in patients with morbid obesity. Diabetes Metab Syndr Obes. 2021, 14:487-95. 10.2147\/DMSO.S286334","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/nu10091153","article-title":"Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence","volume":"10","author":"Cicero AF","year":"2018","unstructured":"Cicero AF, Colletti A, Bellentani S. Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence. Nutrients. 2018, 10:1153. 10.3390\/nu10091153","journal-title":"Nutrients"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091379","article-title":"Micronutrient antioxidants and nonalcoholic fatty liver disease","volume":"17","author":"Chen G","year":"2016","unstructured":"Chen G, Ni Y, Nagata N, Xu L, Ota T. Micronutrient antioxidants and nonalcoholic fatty liver disease. Int J Mol Sci. 2016, 17:1379. 10.3390\/ijms17091379","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1991","article-title":"Role of Vitamin E in nonalcoholic fatty liver disease","volume":"71","author":"Nagashimada M","year":"2019","unstructured":"Nagashimada M, Ota T. Role of Vitamin E in nonalcoholic fatty liver disease. IUBMB Life. 2019, 71:516-22. 10.1002\/iub.1991","journal-title":"IUBMB Life"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113302","article-title":"Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): an update","volume":"12","author":"Barchetta I","year":"2020","unstructured":"Barchetta I, Cimini FA, Cavallo MG. Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): an update. Nutrients. 2020, 12:3302. 10.3390\/nu12113302","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i36.8078","article-title":"Pediatric non-alcoholic fatty liver disease: recent solutions, unresolved issues, and future research directions","volume":"22","author":"Clemente MG","year":"2016","unstructured":"Clemente MG, Mandato C, Poeta M, Vajro P. Pediatric non-alcoholic fatty liver disease: recent solutions, unresolved issues, and future research directions. World J Gastroenterol. 2016, 22:8078-93. 10.3748\/wjg.v22.i36.8078","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.01.009","article-title":"Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches","volume":"15","author":"Borrelli A","year":"2018","unstructured":"Borrelli A, Bonelli P, Tuccillo FM, Goldfine ID, Evans JL, Buonaguro FM, Mancini A. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches. Redox Biol. 2018, 15:467-79. 10.1016\/j.redox.2018.01.009","journal-title":"Redox Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092762","article-title":"New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress","volume":"12","author":"Ferro D","year":"2020","unstructured":"Ferro D, Baratta F, Pastori D, Cocomello N, Colantoni A, Angelico F, Del Ben M. New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress. Nutrients. 2020, 12:2762. 10.3390\/nu12092762","journal-title":"Nutrients"},{"key":"ref15","article-title":"Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease","volume":"24","author":"Kong L","year":"2017","unstructured":"Kong L, Lu Y, Zhang S, Nan Y, Qiao L. Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease. Discov Med. 2017, 24:95-106.","journal-title":"Discov Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i19.2083","article-title":"Mediterranean diet and nonalcoholic fatty liver disease","volume":"24","author":"Anania C","year":"2018","unstructured":"Anania C, Perla FM, Olivero F, Pacifico L, Chiesa C. Mediterranean diet and nonalcoholic fatty liver disease. World J Gastroenterol. 2018, 24:2083-94. 10.3748\/wjg.v24.i19.2083","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0609-1","article-title":"Liver DNA methylation of FADS2 associates with FADS2 genotype","volume":"11","author":"Walle P","year":"2019","unstructured":"Walle P, M\u00e4nnist\u00f6 V, de Mello VD, et al.. Liver DNA methylation of FADS2 associates with FADS2 genotype. Clin Epigenetics. 2019, 11:10. 10.1186\/s13148-019-0609-1","journal-title":"Clin Epigenetics"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2018.07.004","article-title":"Micronutrients in nonalcoholic fatty liver disease pathogenesis","volume":"6","author":"Pickett-Blakely O","year":"2018","unstructured":"Pickett-Blakely O, Young K, Carr RM. Micronutrients in nonalcoholic fatty liver disease pathogenesis. Cell Mol Gastroenterol Hepatol. 2018, 6:451-62. 10.1016\/j.jcmgh.2018.07.004","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/diseases6040086","article-title":"The role of Vitamin E in the treatment of NAFLD","volume":"6","author":"Perumpail BJ","year":"2018","unstructured":"Perumpail BJ, Li AA, John N, et al.. The role of Vitamin E in the treatment of NAFLD. Diseases. 2018, 6:86. 10.3390\/diseases6040086","journal-title":"Diseases"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/nu10010029","article-title":"Disturbed Vitamin A metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"10","author":"Saeed A","year":"2017","unstructured":"Saeed A, Dullaart RP, Schreuder TC, Blokzijl H, Faber KN. Disturbed Vitamin A metabolism in non-alcoholic fatty liver disease (NAFLD). Nutrients. 2017, 10:29. 10.3390\/nu10010029","journal-title":"Nutrients"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2021.03.004","article-title":"Vitamins and non-alcoholic fatty liver disease: a molecular insight\u22c6","volume":"5","author":"Raza S","year":"2021","unstructured":"Raza S, Tewari A, Rajak S, Sinha RA. Vitamins and non-alcoholic fatty liver disease: a molecular insight\u22c6. Liver Res. 2021, 5:62-71. 10.1016\/j.livres.2021.03.004","journal-title":"Liver Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.06.009","article-title":"Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis","volume":"1865","author":"Pham TX","year":"2019","unstructured":"Pham TX, Bae M, Kim MB, et al.. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis. Biochim Biophys Acta Mol Basis Dis. 2019, 1865:2451-63. 10.1016\/j.bbadis.2019.06.009","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.yclnex.2019.11.004","article-title":"Association between serum folate levels and fatty liver disease","volume":"29","author":"Vahedi H","year":"2020","unstructured":"Vahedi H, Bavafaetousi N, Zolfaghari P, Yarmohammadi M, Sohrabi MB. Association between serum folate levels and fatty liver disease. Clin Nutr Exp. 2020, 29:30-35. 10.1016\/j.yclnex.2019.11.004","journal-title":"Clin Nutr Exp"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.20-142","article-title":"Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial","volume":"68","author":"Kobayashi T","year":"2021","unstructured":"Kobayashi T, Kessoku T, Ozaki A, et al.. Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial. J Clin Biochem Nutr. 2021, 68:181-6. 10.3164\/jcbn.20-142","journal-title":"J Clin Biochem Nutr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110792","article-title":"Prophylactic and therapeutic effects of different doses of vitamin C on high-fat-diet-induced non-alcoholic fatty liver disease in mice","volume":"131","author":"Zeng Q","year":"2020","unstructured":"Zeng Q, Zhao L, Meng C, et al.. Prophylactic and therapeutic effects of different doses of vitamin C on high-fat-diet-induced non-alcoholic fatty liver disease in mice. Biomed Pharmacother. 2020, 131:110792. 10.1016\/j.biopha.2020.110792","journal-title":"Biomed Pharmacother"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147985","article-title":"Association between dietary Vitamin C intake and non-alcoholic fatty liver disease: a cross-sectional study among middle-aged and older adults","volume":"11","author":"Wei J","year":"2016","unstructured":"Wei J, Lei GH, Fu L, Zeng C, Yang T, Peng SF. Association between dietary Vitamin C intake and non-alcoholic fatty liver disease: a cross-sectional study among middle-aged and older adults. PLoS One. 2016, 11:e0147985. 10.1371\/journal.pone.0147985","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.10.140","article-title":"Vitamin D and liver fibrosis: molecular mechanisms and clinical studies","volume":"109","author":"Udomsinprasert W","year":"2019","unstructured":"Udomsinprasert W, Jittikoon J. Vitamin D and liver fibrosis: molecular mechanisms and clinical studies. Biomed Pharmacother. 2019, 109:1351-60. 10.1016\/j.biopha.2018.10.140","journal-title":"Biomed Pharmacother"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8411","article-title":"Correlation between serum 25-OH vitamin D expression and non-alcoholic fatty liver disease","volume":"19","author":"Cai J","year":"2020","unstructured":"Cai J, Zhang Z, Liu J, Xiao X, Wang C, Deng M, Chen L. Correlation between serum 25-OH vitamin D expression and non-alcoholic fatty liver disease. Exp Ther Med. 2020, 19:1681-6. 10.3892\/etm.2020.8411","journal-title":"Exp Ther Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v10.i1.142","article-title":"Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: a PRISMA compliant systematic review and meta-analysis of pooled data","volume":"10","author":"Saberi B","year":"2018","unstructured":"Saberi B, Dadabhai AS, Nanavati J, Wang L, Shinohara RT, Mullin GE. Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: a PRISMA compliant systematic review and meta-analysis of pooled data. World J Hepatol. 2018, 10:142-54. 10.4254\/wjh.v10.i1.142","journal-title":"World J Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i38.5812","article-title":"Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis?","volume":"26","author":"Cao Y","year":"2020","unstructured":"Cao Y, Shu XB, Yao Z, Ji G, Zhang L. Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis?. World J Gastroenterol. 2020, 26:5812-21. 10.3748\/wjg.v26.i38.5812","journal-title":"World J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4103\/ijpvm.IJPVM_499_17","article-title":"Effect of Vitamin D on non-alcoholic fatty liver disease: a systematic review of randomized controlled clinical trials","volume":"10","author":"Hariri M","year":"2019","unstructured":"Hariri M, Zohdi S. Effect of Vitamin D on non-alcoholic fatty liver disease: a systematic review of randomized controlled clinical trials. Int J Prev Med. 2019, 10:14. 10.4103\/ijpvm.IJPVM_499_17","journal-title":"Int J Prev Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9018","article-title":"Vitamin E as an adjuvant treatment for non-alcoholic fatty liver disease in adults: a systematic review of randomized controlled trials","volume":"12","author":"Usman M","year":"2020","unstructured":"Usman M, Bakhtawar N. Vitamin E as an adjuvant treatment for non-alcoholic fatty liver disease in adults: a systematic review of randomized controlled trials. Cureus. 2020, 12:e9018. 10.7759\/cureus.9018","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9090808","article-title":"Dietary intervention accelerates NASH resolution depending on inflammatory status with minor additive effects on hepatic injury by Vitamin E supplementation","volume":"9","author":"Klaebel JH","year":"2020","unstructured":"Klaebel JH, Rakipovski G, Andersen B, Lykkesfeldt J, Tveden-Nyborg P. Dietary intervention accelerates NASH resolution depending on inflammatory status with minor additive effects on hepatic injury by Vitamin E supplementation. Antioxidants (Basel). 2020, 9:808. 10.3390\/antiox9090808","journal-title":"Antioxidants (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/63283-the-role-of-vitamins-in-non-alcoholic-fatty-liver-disease-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:28Z","timestamp":1707507208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/63283-the-role-of-vitamins-in-non-alcoholic-fatty-liver-disease-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.16855","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,3]]}}}